AML/KYC systems are costly, intrusive, and largely ineffective globally.Compliance prioritises process over actually stopping criminal flows.Citizens ...

Eurex, owned by Deutsche Börse, confirmed that the ECB and national central banks will become members of its cleared repo ...

As the Hong Kong daily "HongKong Telegraph" recently learned, the SCANDIC TRUST GROUP, an internationally operating ...

ELEVENTH. The ABM will publish a Guidance Note outlining the banks' obligations derived from the August 28, 2024, amendments to the AML Regulations, especially those provisions aimed at preventing the ...

CLN-049 demonstrated anti-leukemic activity, including multiple complete responses, in a heavily pretreated population of patients with r/r AML, ...

The International Federation of Accountants is teaming with the International Bar Association to combat money laundering, ...

First and only therapy FDA approved in both R/R acute myeloid leukemia (AML) with an NPM1 mutation and R/R acute leukemia with a KMT2A ...

The US FDA has approved the supplemental new drug application (sNDA) for revumenib (Revuforj) in the treatment of relapsed or refractory (R/R) mutant nucleophosmin 1 (m NPM1) acute myeloid leukemia ...

Revuforj is approved for relapsed/refractory AML with NPM1 mutation in patients aged one year and older, based on AUGMENT-101 trial results. The drug inhibits menin's interaction with KMT2A, slowing ...

The Investment Adviser Association and the Investment Company Institute voiced support for the two-year postponement, citing a need for tailored anti-money laundering requirements.

There is a palpable tension that governs most financial crime programs in the United States. Banks build their AML programs on the principle of risk-based compliance. They say it to regulators, write ...

Abhishek Bali, CEO & Co-founder, ZIGRAM. "Our collaboration with PSPAN represents a meaningful step in enabling Nepal’s payment ecosystem to access world-class AML technologies tailored for local ...